Current concept and update of the macrophage plasticity concept: Intracellular mechanisms of reprogramming and M3 macrophage "switch" phenotype

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Malyshev, Igor ^a,b,c   Malyshev, Yuri ^d  

^a A I EVDOKIMOV MOSCOW STATE UNIVERSITY OF MEDICINE AND DENTISTRY   (Russian Federation)

^b INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^d MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

HUMAN; HYPOXIA; IMMUNITY; INFLAMMATION; MACROPHAGE; MACROPHAGE PLASTICITY; MOLECULAR MECHANICS; NUCLEAR REPROGRAMMING; PATHOGENESIS; PHENOTYPE; PLASTICITY; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CELL PLASTICITY; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL PLASTICITY; CELLULAR REPROGRAMMING; HUMANS; MACROPHAGES; PHENOTYPE; SIGNAL TRANSDUCTION;

EID: 84941248339     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/341308     Document Type: Review

References (129)

1. D. M. Mosser and J. P. Edwards, "Exploring the full spectrum of macrophage activation," Nature Reviews Immunology, vol. 8, no. 12, pp. 958-969, 2008.
2. C. Schulz, E. G. Perdiguero, L. Chorro et al., "A lineage of myeloid cells independent of myb and hematopoietic stem cells," Science, vol. 335, no. 6077, pp. 86-90, 2012.
3. S. Yona, K. W. Kim, Y. Wolf et al., "Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis," Immunity, vol. 38, pp. 79-91, 2013.
4. J. A. Ross and M. J. Auger, "The biology of the macrophage," in The Macrophage, B. Burke and C. E. Lewis, Eds., Oxford University Press, Oxford, UK, 2nd edition, 2002.
5. S. Akira, S. Uematsu, and O. Takeuchi, "Pathogen recognition and innate immunity," Cell, vol. 124, no. 4, pp. 783-801, 2006.
6. B. Bottazzi, A. Doni, C. Garlanda, and A. Mantovani, "An integrated view of humoral innate immunity: pentraxins as a paradigm," Annual Review of Immunology, vol. 28, pp. 157-183, 2010.
7. F. Geissmann, M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley, "Development of monocytes, macrophages, and dendritic cells," Science, vol. 327, no. 5966, pp. 656-661, 2010.
8. W. Noël, G. Raes, G. H. Ghassabeh, P. De Baetselier, and A. Beschin, "Alternatively activated macrophages during parasite infections," Trends in Parasitology, vol. 20, no. 3, pp. 126-133, 2004.
9. M. Benoit, B. Desnues, and J.-L. Mege, "Macrophage polarization in bacterial infections," Journal of Immunology, vol. 181, no. 6, pp. 3733-3739, 2008.
10. A. Mantovani, A. Sica, and M. Locati, "New vistas on macrophage diferentiation and activation," European Journal of Immunology, vol. 37, no. 1, pp. 14-16, 2007.
11. M. Sharma, "Chemokines and their receptors: orchestrating a fne balance between health and disease," Critical Reviews in Biotechnology, vol. 30, no. 1, pp. 1-22, 2010.
12. F. H. Falcone, H. Haas, and B. F. Gibbs, "The human basophil: a new appreciation of its role in immune responses," Blood, vol. 96, no. 13, pp. 4028-4038, 2000.
13. A. D'Andrea, M. Aste-Amezaga, N. M. Valiante, X. Ma, M. Kubin, and G. Trinchieri, "Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells," Journal of Experimental Medicine, vol. 178, no. 3, pp. 1041-1048, 1993.
14. C. D. Mills, K. Kincaid, J. M. Alt, M. J. Heilman, and A. M. Hill, "M-1/M-2 macrophages and the T1/T2 paradigm," Journal of Immunology, vol. 164, no. 12, pp. 6166-6173, 2000.
15. F. O. Martinez, A. Sica, A. Mantovani, and M. Locati, "Macrophage activation and polarization," Frontiers in Bioscience, vol. 13, no. 2, pp. 453-461, 2008.
16. A. Saccani, T. Schioppa, C. Porta et al., "p50 nuclear factor-αB overexpression in tumor-associated macrophages inhibits M1 infammatory responses and antitumor resistance," Cancer Research, vol. 66, no. 23, pp. 11432-11440, 2006.
17. A. Mantovani and M. Locati, "Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization lessons and open questions," Arteriosclerosis, Trombosis, and Vascular Biology, vol. 33, no. 7, pp. 1478-1483, 2013.
18. S. K. Biswas and A. Mantovani, "Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm," Nature Immunology, vol. 11, no. 10, pp. 889-896, 2010.
19. S. Gordon, "Alternative activation of macrophages," Nature Reviews Immunology, vol. 3, no. 1, pp. 23-35, 2003.
20. E. Jang, S. Lee, J.-H. Kim et al., "Secreted protein lipocalin-2 promotes microglial M1 polarization," The FASEB Journal, vol. 27, no. 3, pp. 1176-1190, 2013.
21. A. Mercalli, I. Calavita, E. Dugnani et al., "Rapamycin unbalances the polarization of human macrophages to M1," Immunology, vol. 140, no. 2, pp. 179-190, 2013.
22. N. Hirohashi and D. C. Morrison, "Low-dose lipopolysaccha-ride (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro," Infection and Immunity, vol. 64, no. 3, pp. 1011-1015, 1996.
23. X. Zhang and D. C. Morrison, "Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages," Journal of Leukocyte Biology, vol. 54, no. 5, pp. 444-450, 1993.
24. N. Takeda, E. L. O'Dea, A. Doedens et al., "Diferential activation and antagonistic function of HIF-α isoforms in macrophages are essential for NO homeostasis," Genes and Development, vol. 24, no. 5, pp. 491-501, 2010.
25. N.-B. Hao, M.-H. Lü, Y.-H. Fan, Y.-L. Cao, Z.-R. Zhang, and S.M. Yang, "Macrophages in tumor microenvironments and the progression of tumors," Clinical and Developmental Immunology, vol. 2012, Article ID 948098, 11 pages, 2012.
26. C. Lewis and C. Murdoch, "Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies," The American Journal of Pathology, vol. 167, no. 3, pp. 627-635, 2005.
27. C. C. Jancic, M. Cabrini, M. L. Gabelloni et al., "Low extracellular pH stimulates the production of IL-1α by human monocytes," Cytokine, vol. 57, no. 2, pp. 258-268, 2012.
28. I. Y. Malyshev, E. B. Manukhina, and Y. I. Malyshev, "Physiological organizationof immune response based onthe homeostatic mechanism of matrix reprogramming: implication in tumor and biotechnology," Medical Hypotheses, vol. 82, no. 6, pp. 754-765, 2014.
29. F. Rey-Giraud, M. Hafner, and C. H. Ries, "In vitro generation of monocyte-derived macrophages under serum-free conditions improves their tumor promoting functions," PLoS ONE, vol. 7, no. 8, Article ID e42656, 2012.
30. L. M. Shaughnessy and J. A. Swanson, "The role of the activated macrophage in clearing Listeria monocytogenes infection," Frontiers in Bioscience, vol. 12, no. 7, pp. 2683-2692, 2007.
31. R. Chacón-Salinas, J. Serafín-López, R. Ramos-Payán et al., "Diferential pattern of cytokine expression by macrophages infected in vitro with diferent Mycobacterium tuberculosis genotypes," Clinical & Experimental Immunology, vol. 140, no. 3, pp. 443-449, 2005.
32. P. A. Sieling, J. S. Abrams, M. Yamamura et al., "Immuno-suppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy," The Journal of Immunology, vol. 150, no. 12, pp. 5501-5510, 1993.
33. P. J. Murray and T. A. Wynn, "Obstacles and opportunities for understanding macrophage polarization," Journal of Leukocyte Biology, vol. 89, no. 4, pp. 557-563, 2011.
34. A. Mantovani, S. K. Biswas, M. R. Galdiero, A. Sica, and M. Locati, "Macrophage plasticity and polarization in tissue repair and remodelling," The Journal of Pathology, vol. 229, no. 2, pp. 176-185, 2013.
35. F. O. Martinez, L. Helming, and S. Gordon, "Alternative activation of macrophages: an immunologic functional perspective," Annual Review of Immunology, vol. 27, pp. 451-483, 2009.
36. S. Gordon and F. O. Martinez, "Alternative activation of macrophages: mechanism and functions," Immunity, vol. 32, no. 5, pp. 593-604, 2010.
37. D. Zhou, C. Huang, Z. Lin et al., "Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways," Cellular Signalling, vol. 26, no. 2, pp. 192-197, 2014.
38. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., "Obesity is associated with macrophage accumulation in adipose tissue," The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796-1808, 2003.
39. R. Derynck and Y. E. Zhang, "Smad-dependent and Smad-independent pathways in TGF-α family signalling," Nature, vol. 425, no. 6958, pp. 577-584, 2003.
40. J. P. Luyendyk, G. A. Schabbauer, M. Tencati, T. Holscher, R. Pawlinski, and N. Mackman, "Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages," The Journal of Immunology, vol. 180, no. 6, pp. 4218-4226, 2008.
41. A. Arranz, C. Doxaki, E. Vergadi et al., "Akt1 and Akt2 protein kinases diferentially contribute to macrophage polarization," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 24, pp. 9517-9522, 2012.
42. A. Androulidaki, D. Iliopoulos, A. Arranz et al., "The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs," Immunity, vol. 31, no. 2, pp. 220-231, 2009.
43. D. Rufell, F. Mourkioti, A. Gambardella et al., "A CREB-C/EBPα cascade induces M2 macrophage-specifc gene expression and promotes muscle injury repair," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 41, pp. 17475-17480, 2009.
44. B. D'Souza, A. Miyamoto, and G. Weinmaster, "The many facets of Notch ligands," Oncogene, vol. 27, no. 38, pp. 5148-5167, 2008.
45. H. Xu, J. Zhu, S. Smith et al., "Notch-RBP-J signaling regulates the transcription factor IRF8 to promote infammatory macrophage polarization," Nature Immunology, vol. 13, no. 7, pp. 642-650, 2012.
46. E. Fung, S.-M. T. Tang, J. P. Canner et al., "Delta-like 4 induces Notch signaling in macrophages: implications for infamma-tion," Circulation, vol. 115, no. 23, pp. 2948-2956, 2007.
47. J. Liu, X. Guan, T. Tamura, K. Ozato, and X. Ma, "Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein," The Journal of Biological Chemistry, vol. 279, no. 53, pp. 55609-55617, 2004.
48. J. Zhao, J. K. Hee, H. Li et al., "IRF-8/interferon (IFN) consensus sequence-binding protein is involved in toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-α signaling pathways," The Journal of Biological Chemistry, vol. 281, no. 15, pp. 10073-10080, 2006.
49. Y.-C. Wang, F. He, F. Feng et al., "Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses," Cancer Research, vol. 70, no. 12, pp. 4840-4849, 2010.
50. W. Zhang, W. Xu, and S. Xiong, "Blockade of Notch1 signalin g alleviates murine lupus via blunting macrophage activation and M2b polarization," Journal of Immunology, vol. 184, no. 11, pp. 6465-6478, 2010.
51. Y. Kono, S. Kawakami, Y. Higuchi, F. Yamashita, and M. Hashida, "In vitro evaluation of inhibitory efect of nuclear factor-kappab activity by small interfering RNA on pro-tumor characteristics of m2-like macrophages," Biological and Pharmaceutical Bulletin, vol. 37, no. 1, pp. 137-144, 2014.
52. C. Schindler, D. E. Levy, and T. Decker, "JAK-STAT signaling: from interferons to cytokines," The Journal of Biological Chemistry, vol. 282, no. 28, pp. 20059-20063, 2007.
53. P. J. Murray, "The JAK-STAT signaling pathway: input and output integration," The Journal of Immunology, vol. 178, no. 5, pp. 2623-2629, 2007.
54. C. H. Yeh, H. C. Shih, H. M. Hong et al., "Protective efect of wogonin on proinfammatory cytokine generation via Jak1/3-STAT1/3 pathway in lipopolysaccharide stimulated BV2 microglial cells," Toxicology and Industrial Health, 2013.
55. T. Satoh, H. Kidoya, H. Naito et al., "Critical role of Trib1 in diferentiation of tissue-resident M2-like macrophages," Nature, vol. 495, no. 7442, pp. 524-528, 2013.
56. A. Seneviratne, J. Cole, M. Goddard, I. Udalova, R. Krams, and C. Monaco, "M1 macrophages and irf5 exacerbate atheroscle rotic disease," Heart, vol. 99, article A103, 2013.
57. J. Eguchi, X. Kong, M. Tenta, X. Wang, S. Kang, and E. D. Rosen, "Interferon regulatory factor 4 regulates obesity-induced infammation through regulation of adipose tissue macrophage polarization," Diabetes, vol. 62, no. 10, pp. 3394-3403, 2013.
58. T. Krausgruber, K. Blazek, T. Smallie et al., "IRF5 promotes infammatory macrophage polarization and TH1-TH17 responses," Nature Immunology, vol. 12, no. 3, pp. 231-238, 2011.
59. X. Hu, C. Herrero, W.-P. Li et al., "Sensitization of IFN-α Jak-STAT signaling during macrophage activation," Nature Immunology, vol. 3, no. 9, pp. 859-866, 2002.
60. A. Bhattacharjee, M. Shukla, V. P. Yakubenko, A. Mulya, S. Kundu, and M. K. Cathcart, "IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages," Free Radical Biology and Medicine, vol. 54, pp. 1-16, 2013.
61. O. M. Pello, M. De Pizzol, M. Mirolo et al., "Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology," Blood, vol. 119, no. 2, pp. 411-421, 2012.
62. J. K. Riley, K. Takeda, S. Akira, and R. D. Schreiber, "Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-infammatory action," The Journal of Biological Chemistry, vol. 274, no. 23, pp. 16513-16521, 1999.
63. F. Driessler, K. Venstrom, R. Sabat, K. Asadullah, and A. J. Schottelius, "Molecular mechanisms of interleukin-10-mediated inhibition of NF-αB activity: a role for p50," Clinical and Experimental Immunology, vol. 135, no. 1, pp. 64-73, 2004.
64. B. A. Croker, H. Kiu, and S. E. Nicholson, "SOCS regulation of the JAK/STAT signalling pathway," Seminars in Cell & Developmental Biology, vol. 19, no. 4, pp. 414-422, 2008.
65. H. Qin, A. T. Holdbrooks, Y. Liu, S. L. Reynolds, L. L. Yanag-isawa, and E. N. Benveniste, "SOCS3 defciency promotes M1 macrophage polarization and infammation," The Journal of Immunology, vol. 189, no. 7, pp. 3439-3448, 2012.
66. J. Massagúe, J. Seoane, and D. Wotton, "Smad transcription factors," Genes & Development, vol. 19, no. 23, pp. 2783-2810, 2005.
67. G. Raes, L. Brys, B. K. Dahal et al., "Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway infammation," Journal of Leukocyte Biology, vol. 77, no. 3, pp. 321-327, 2005.
68. M. Landström, "The TAK1-TRAF6 signalling pathway," The International Journal of Biochemistry & Cell Biology, vol. 42, no. 5, pp. 585-589, 2010.
69. K. Takeda, T. Kaisho, and S. Akira, "Toll-like receptors," Annual Review of Immunology, vol. 21, pp. 335-376, 2003.
70. L. A. J. O'Neill and A. G. Bowie, "The family of fve: TIR-domain-containing adaptors in Toll-like receptor signalling," Nature Reviews Immunology, vol. 7, no. 5, pp. 353-364, 2007.
71. P. G. Motshwene, M. C. Moncriefe, J. G. Grossmann et al., "An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4," The Journal of Biological Chemistry, vol. 284, no. 37, pp. 25404-25411, 2009.
72. H. Ye, J. R. Arron, B. Lamothe et al., "Distinct molecular mechanism for initiating TRAF6 signalling," Nature, vol. 418, no. 6896, pp. 443-447, 2002.
73. J. D. Woronicz, X. Gao, Z. Cao, M. Rothe, and D. V. Goeddel, "IαB kinase-α: NF-αB activation and complex formation with IαB kinase-α and NIK," Science, vol. 278, no. 5339, pp. 866-869, 1997.
74. J. Napetschnig and H. Wu, "Molecular basis of NF-αB signaling," Annual Review of Biophysics, vol. 42, no. 1, pp. 443-468, 2013.
75. H. Kitamura, K. Kanehira, K. Okita, M. Morimatsu, and M. Saito, "MAIL, a novel nuclear IαB protein that potentiates LPS-induced IL-6 production," FEBS Letters, vol. 485, no. 1, pp. 53-56, 2000.
76. C. Porta, M. Rimoldi, G. Raes et al., "Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor αB," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 35, pp. 14978-14983, 2009.
77. G. Bonizzi and M. Karin, "The two NF-αB activation pathways and their role in innate and adaptive immunity," Trends in Immunology, vol. 25, no. 6, pp. 280-288, 2004.
78. K. Luu, C. J. Greenhill, A. Majoros, T. Decker, B. J. Jenkins, and A. Mansell, "STAT1 plays a role in TLR signal transduction and infammatory responses," Immunology & Cell Biology, vol. 92, no. 9, pp. 761-769, 2014.
79. G. L. Semenza, "Oxygen homeostasis," Wiley Interdisciplinary Reviews: Systems Biology and Medicine, vol. 2, no. 3, pp. 336-361, 2010.
80. 2 sensing," Science, vol. 292, no. 5516, pp. 464-468, 2001.
81. E. D. Ponomarev, T. Veremeyko, and H. L. Weiner, "MicroRNAs are universal regulators of diferentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS," Glia, vol. 61, no. 1, pp. 91-103, 2013.
82. D. P. Bartel, "MicroRNAs: target recognition and regulatory functions," Cell, vol. 136, no. 2, pp. 215-233, 2009.
83. V. A. Galitskiy, "Hypothesis about the mechanism of initiation of small RNA DNA methylation de novo and allelic exclusion," Cytology, vol. 50, no. 4, pp. 277-286, 2008.
84. M. Locati, A. Mantovani, and A. Sica, "Macrophage activation and polarization as an adaptive component of innate immunity," Advances in Immunology, vol. 120, pp. 163-184, 2013.
85. S. Bala, M. Marcos, K. Kodys et al., "Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor α (TNFα) production via increased mRNA halflife in alcoholic liver disease," Journal of Biological Chemistry, vol. 286, no. 2, pp. 1436-1444, 2011.
86. P. Wang, J. Hou, L. Lin et al., "Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1," Journal of Immunology, vol. 185, no. 10, pp. 6226-6233, 2010.
87. R. T. Martinez-Nunez, F. Louaf, and T. Sanchez-Elsner, "The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor α1 (IL13Rα1)," The Journal of Biological Chemistry, vol. 286, no. 3, pp. 1786-1794, 2011.
88. J. Chen, J. Olsen, S. Ford et al., "A new isoform of interleukin-3 receptor α with novel diferentiation activity and high afnity binding mode," The Journal of Biological Chemistry, vol. 284, no. 9, pp. 5763-5773, 2009.
89. F. Louaf, R. T. Martinez-Nunez, and T. Sanchez-Elsner, "MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-α," The Journal of Biological Chemistry, vol. 285, no. 53, pp. 41328-41336, 2010.
90. M. Nazari-Jahantigh, Y. Wei, H. Noels et al., "MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages," Journal of Clinical Investigation, vol. 122, no. 11, pp. 4190-4202, 2012.
91. D. P. Ramji and P. Foka, "CCAAT/enhancer-binding proteins: structure, function and regulation," Biochemical Journal, vol. 365, part 3, pp. 561-575, 2002.
92. M. He, Z. Xu, T. Ding, D.-M. Kuang, and L. Zheng, "MicroRNA-155 regulates infammatory cytokine production in tumor-associated macrophages via targeting C/EBPα," Cellular & Molecular Immunology, vol. 6, no. 5, pp. 343-352, 2009.
93. S.-W. Kim, K. Ramasamy, H. Bouamar, A.-P. Lin, D. Jiang, and R. C. T. Aguiar, "MicroRNAs miR-125a and miR-125b constitutively activate the NF-kappaB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 20, pp. 7865-7870, 2012.
94. J. W. Graf, A. M. Dickson, G. Clay, A. P. McCafrey, and M. E. Wilson, "Identifying functional microRNAs in macrophages with polarized phenotypes," The Journal of Biological Chemistry, vol. 287, no. 26, pp. 21816-21825, 2012.
95. A. A. Chaudhuri, A. Y.-L. So, N. Sinha et al., "MicroRNA-125b potentiates macrophage activation," The Journal of Immunology, vol. 187, no. 10, pp. 5062-5068, 2011.
96. E. Tili, J.-J. Michaille, A. Cimino et al., "Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-α stimulation and their possible roles in regulating the response to endotoxin shock," The Journal of Immunology, vol. 179, no. 8, pp. 5082-5089, 2007.
97. K. D. Taganov, M. P. Boldin, K.-J. Chang, and D. Baltimore, "NF-αB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses," Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 33, pp. 12481-12486, 2006.
98. F. Bazzoni, M. Rossato, M. Fabbri et al., "Induction and regulatory function of miR-9 in human monocytes and neu-trophils exposed to proinfammatory signals," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 13, pp. 5282-5287, 2009.
99. F. J. Sheedy, E. Palsson-Mcdermott, E. J. Hennessy et al., "Negative regulation of TLR4 via targeting of the proinfammatory tumor suppressor PDCD4 by the microRNA miR-21," Nature Immunology, vol. 11, no. 2, pp. 141-147, 2010.
100. G. Liu, A. Friggeri, Y. Yang, Y.-J. Park, Y. Tsuruta, and E. Abraham, "miR-147, a microRNA that is induced upon toll-like receptor stimulation, regulates murine macrophage infamma-tory responses," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 37, pp. 15819-15824, 2009.
101. M. A. Nahid, K. M. Pauley, M. Satoh, and E. K. L. Chan, "miR-146a is critical for endotoxin-induced tolerance: implication in innate immunity," The Journal of Biological Chemistry, vol. 284, no. 50, pp. 34590-34599, 2009.
102. M. Rossato, G. Curtale, N. Tamassia et al., "IL-10-induced microRNA-187 negatively regulates TNF-α, IL-6, and IL-12p40 production in TLR4-stimulated monocytes," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 45, pp. E3101-E3110, 2012.
103. G. Curtale, M. Mirolo, T. A. Renzi, M. Rossato, F. Bazzoni, and M. Locati, "Negative regulation of toll-like receptor 4 signaling by IL-10 dependent microRNA-146b," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 28, pp. 11499-11504, 2013.
104. M. L. Squadrito, M. Etzrodt, M. De Palma, and M. J. Pittet, "microRNA-mediated control of macrophages and its implications for cancer," Trends in Immunology, vol. 34, no. 7, pp. 350-359, 2013.
105. J. I. Odegaard and A. Chawla, "Alternative macrophage activation and metabolism," Annual Review of Pathology: Mechanisms of Disease, vol. 6, pp. 275-297, 2011.
106. B. N. Melgert, N. H. ten Hacken, B. Rutgers, W. Timens, D. S. Postma, and M. N. Hylkema, "More alternative activation of macrophages in lungs of asthmatic patients," Journal of Allergy and Clinical Immunology, vol. 127, no. 3, pp. 831-833, 2011.
107. T. A. Reese, H.-E. Liang, A. M. Tager et al., "Chitin induces accumulation in tissue of innate immune cells associated with allergy," Nature, vol. 447, no. 7140, pp. 92-96, 2007.
108. T. Chanmee, P. Ontong, K. Konno, and N. Itano, "Tumor-associated macrophages as major players in the tumor microenvironment," Cancers, vol. 6, no. 3, pp. 1670-1690, 2014.
109. J.-M. Cavaillon and M. Adib-Conquy, "Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis," Critical Care, vol. 10, no. 5, article 233, 2006.
110. T. Hagemann, T. Lawrence, I. McNeish et al., "'Re-educating' tumor-associated macrophages by targeting NF-αB," The Journal of Experimental Medicine, vol. 205, no. 6, pp. 1261-1268, 2008.
111. D. Duluc, M. Corvaisier, S. Blanchard et al., "Interferon-α reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor-associated macrophages," International Journal of Cancer, vol. 125, no. 2, pp. 367-373, 2009.
112. R. D. Schreiber, L. J. Old, and M. J. Smyth, "Cancer immu-noediting: integrating immunity's roles in cancer suppression and promotion," Science, vol. 331, no. 6024, pp. 1565-1570, 2011.
113. M. Benoit, B. Barbarat, A. Bernard, D. Olive, and J.-L. Mege, "Coxiella burnetii, the agent of Q fever, stimulates an atypical M2 activation program in human macrophages," European Journal of Immunology, vol. 38, no. 4, pp. 1065-1070, 2008.
114. K. A. Pike, A. P. Hutchins, V. Vinette et al., "Protein tyrosine phosphatase 1B is a regulator of the interleukin-10-induced transcriptional program in macrophages," Science Signaling, vol. 7, no. 324, article ra43, 2014.
115. E. J. Pearce and A. S. MacDonald, "The immunobiology of schistosomiasis," Nature Reviews Immunology, vol. 2, no. 7, pp. 499-511, 2002.
116. A. P. Moreira and C. M. Hogaboam, "Macrophages in allergic asthma: fne-tuning their pro-and anti-infammatory actions for disease resolution," Journal of Interferon and Cytokine Research, vol. 31, no. 6, pp. 485-491, 2011.
117. M. E. Shaul, G. Bennett, K. J. Strissel, A. S. Greenberg, and M. S. Obin, "Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet- induced obesity in mice," Diabetes, vol. 59, no. 5, pp. 1171-1181, 2010.
118. J. Lee, B. French, T. Morgan, and S. W. French, "The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2," Experimental and Molecular Pathology, vol. 96, no. 1, pp. 118-125, 2014.
119. A. Mantovani and A. Sica, "Macrophages, innate immunity and cancer: balance, tolerance, and diversity," Current Opinion in Immunology, vol. 22, no. 2, pp. 231-237, 2010.
120. I. Malyshev and S. Lyamina, "Imbalance of M1/M2 alveolar macrophages phenotype in bronchial asthma," The FASEB Journal, vol. 28, no. 1, Article ID LB506, 2014.
121. S. Lyamina and I. Malyshev, "Imbalance of immune response functional phenotype and alveolar macrophages phenotype in COPD," in Proceedings of the International Congress of European Respiratory Society, p. 1483, Munich, Germany, September 2014.
122. S. V. Lyamina, T. Y. Vedenikin, O. A. Borodovitsyna, I. A. Suvorova, S. L. Shimshelashvili, and I. Y. Malyshev, "Reprogramming mechanisms of nitric oxide synthesis in m1 and m2 phenotypes of mice peritoneal macrophages in vitro in the presence of diferent concentrations of serum," Medical Immunology, vol. 1-2, no. 14, pp. 127-132, 2012.
123. R. P. Schleimer, "Efects of glucocorticosteroids on infamma-tory cells relevant to their therapeutic applications in asthma," American Review of Respiratory Disease, vol. 141, no. 2, part 2, pp. S59-S69, 1990.
124. J. Bystrom, I. Evans, J. Newson et al., "Resolution-phase macrophages possess a unique infammatory phenotype that is controlled by cAMP," Blood, vol. 112, no. 10, pp. 4117-4127, 2008.
125. R. J. da Silva, M. G. da Silva, L. C. Vilela, and D. Fecchio, "Cytokine profle of Ehrlich ascites tumor treated with Bothrops jararaca venom," Mediators of Infammation, vol. 11, no. 4, pp. 197-201, 2002.
126. A. Sindrilaru, T. Peters, S. Wieschalka et al., "An unrestrained proinfammatory M1 macrophage population induced by iron impairs wound healing in humans and mice," The Journal of Clinical Investigation, vol. 121, no. 3, pp. 985-997, 2011.
127. F. Xu, Y. Kang, H. Zhang et al., "Akt1-mediated regulation of macrophage polarization in a murine model of staphylococcus aureus pulmonary infection," Journal of Infectious Diseases, vol. 208, no. 3, pp. 528-538, 2013.
128. I. Raphael, S. Nalawade, T. N. Eagar, and T. G. Forsthuber, "T cell subsets and their signature cytokines in autoimmune and infammatory diseases," Cytokine, vol. 74, no. 1, pp. 5-17, 2015.
129. J. Barbi, D. Pardoll, and F. Pan, "Treg functional stability and its responsiveness to the microenvironment," Immunological Reviews, vol. 259, no. 1, pp. 115-139, 2014.